Lantheus Grants Rights for the Use of its Microbubbles to SonoThera for its Ultrasound-Guided Nonviral Gene Therapy Platform

(marketscreener.com) NORTH BILLERICA, Mass., Dec. 12, 2022 -- Lantheus Holdings, Inc. , a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, announced a strategic collaboration with SonoThera, Inc., a biotechnology company dedicated...https://www.marketscreener.com/quote/stock/LANTHEUS-HOLDINGS-INC-17053982/news/Lantheus-Grants-Rights-for-the-Use-of-its-Microbubbles-to-SonoThera-for-its-Ultrasound-Guided-Nonvir-42527067/?utm_medium=RSS&utm_content=20221212